You just read:

Medical Marijuana, Inc. Investment AXIM® Biotech Announces Enrolled Patients Begin Phase II Trial For The Treatment Of Irritable Bowel Syndrome (IBS) With CanChew Plus® Cannabidiol (CBD) Chewing Gum

News provided by

Medical Marijuana, Inc.

Mar 07, 2017, 09:15 ET